Axillary clearance and chemotherapy rates in ER+HER2− breast cancer: secondary analysis of the SENOMAC trial
Lisa Rydén, Michalis Kontos, Roger Olofsson Bagge, Thorsten Kühn et al.
Citations
2 citations
Journal
The Lancet Regional Health - Europe
Topics
Breast Cancer Treatment Studies
Field-Weighted Citation Impact (FWCI)
0.57
article
Axillary clearance and chemotherapy rates in ER+HER2− breast cancer: secondary analysis of the SENOMAC trial
Lisa Rydén, Michalis Kontos, Roger Olofsson Bagge, Thorsten Kühn, Dan Lundstedt, Peer Christiansen, Malin Sund, Jan Frisell, Jana de Boniface, Leif Bergkvist, Tove Filtenborg Tvedskov, Sara Alkner, Robert Szulkin, Toralf Reimer, Yvette Andersson, Oreste Davide Gentilini, Birgitte Vrou Offersen
article en
2 citations
Abstract
No abstract available for this paper.
Publication Tag
The Lancet Regional Health - EuropeVol. 47
Institutions
Uppsala University (SE), University of Copenhagen (DK), Karolinska University Hospital (SE), University of Helsinki (FI), Vita-Salute San Raffaele University (IT), Lund University (SE), Universität Ulm (DE), National and Kapodistrian University of Athens (GR), Aarhus University (DK), Helsinki University Hospital (FI), Sahlgrenska University Hospital (SE), Aarhus University Hospital (DK), Gentofte Hospital (DK), Karolinska Institutet (SE), Saint Göran Hospital (SE), Västmanlands sjukhus Västerås (SE), IRCCS Ospedale San Raffaele (IT), Skåne University Hospital (SE), Centre for Cosmology and Particle Physics Phenomenology (DK), University of Rostock (DE), University of Gothenburg (SE), Umeå University (SE), Cytel (United States) (US)